| Attribute |
Value |
| 52 Week Change |
0.92678225 |
| Address1 |
Im Neuenheimer Feld 584 |
| All Time High |
27.36 |
| All Time Low |
8.4 |
| Average Daily Volume10 Day |
18,780 |
| Average Daily Volume3 Month |
15,520 |
| Average Volume |
15,520 |
| Average Volume10Days |
18,780 |
| Bid |
25.9 |
| Bid Size |
1 |
| City |
Heidelberg |
| Country |
Germany |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
20.0 |
| Custom Price Alert Confidence |
HIGH |
| Day High |
26.0 |
| Day Low |
17.12 |
| Ebitda Margins |
0.0 |
| Esg Populated |
0 |
| Exchange |
NGM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
12.31418 |
| Fifty Day Average Change |
7.6858196 |
| Fifty Day Average Change Percent |
0.62414384 |
| Fifty Two Week Change Percent |
92.67822 |
| Fifty Two Week High |
27.36 |
| Fifty Two Week High Change |
-7.3600006 |
| Fifty Two Week High Change Percent |
-0.26900586 |
| Fifty Two Week Low |
8.4 |
| Fifty Two Week Low Change |
11.6 |
| Fifty Two Week Low Change Percent |
1.3809525 |
| Fifty Two Week Range |
8.4 - 27.36 |
| First Trade Date Milliseconds |
1,727,703,000,000 |
| Full Exchange Name |
NasdaqGM |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Implied Shares Outstanding |
136,325,000 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,026-06-11 |
| Language |
en-US |
| Long Business Summary |
VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company utilizes proprietary payloads and genetic code expansion technology to engineer and manufacture homogeneous, stable bioconjugates with defined drug-to-antibody ratios. It also licenses technology platforms to support the development of new therapeutic strategies. The company serves professional clients in the healthcare sector, including those in drug development, biologicals, diagnostics, instrumentation, and partners with research organizations and business partners in the life sciences industry. The company was founded in 2021 and is based in Heidelberg, Germany. |
| Long Name |
Veraxa Biotech AG Ordinary Shares |
| Market |
us_market |
| Market Cap |
2,726,499,840 |
| Market State |
POSTPOST |
| Max Age |
86,400 |
| Message Board Id |
finmb_699307581 |
| New Listing Date |
2,026-06-11 |
| Non Diluted Market Cap |
3,379,496,750 |
| Open |
20.0 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
49 6221 3521330 |
| Post Market Change |
0.0 |
| Post Market Change Percent |
0.0 |
| Post Market Price |
20.0 |
| Post Market Time |
1,781,303,318 |
| Previous Close |
24.79 |
| Price Hint |
2 |
| Profit Margins |
0.0 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-4.790001 |
| Regular Market Change Percent |
-19.32231 |
| Regular Market Day High |
26.0 |
| Regular Market Day Low |
17.12 |
| Regular Market Day Range |
17.12 - 26.0 |
| Regular Market Open |
20.0 |
| Regular Market Previous Close |
24.79 |
| Regular Market Price |
20.0 |
| Regular Market Time |
1,781,294,400 |
| Regular Market Volume |
24,330 |
| Sand P52 Week Change |
0.23177934 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
136,325,000 |
| Short Name |
Veraxa Biotech AG Ordinary Shares |
| Source Interval |
15 |
| Symbol |
VRXA |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
11.073655 |
| Two Hundred Day Average Change |
8.926345 |
| Two Hundred Day Average Change Percent |
0.8060884 |
| Type Disp |
Equity |
| Volume |
24,330 |
| Website |
https://www.veraxa.com |
| Zip |
69,120 |